Large Pharmas See China, India, Others As Best Markets, Not U.S.

The world's large pharmaceutical companies are looking away from the United States to countries in the developing world such as China and India for major sales growth. More than half of the profits of leading drug makers come from the United States, but emerging markets have made themselves more attractive by offering patent protection and higher individual buying power. Drug makers also express concern a President Barack Obama would engineer a requirement the drug suppliers to the U.S. Medicare system negotiate lower prices. A consultant warns, however, the makers need to have products relevant to patients in the emerging markets. (Click here for more